Home / Inspections / 1216239

FDA Inspection 1216239 — OneLegacy

OneLegacy — FEI 3004627938

The FDA completed an inspection of OneLegacy on August 23, 2023 in Redlands, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 23, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Redlands, CA (United States)

Facility

Other inspections at this facility

  • 1060112 (NAI Wed Jun 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 981678 (NAI Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 836734 (NAI Wed May 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 736338 (NAI Thu Jul 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 590132 (NAI Wed May 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources